Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 1982; Volume 21,Issue 1
  • You have access
    Subunit selectivity in the monooxygenase-like activity of tetrameric hemoglobin.
    B L Ferraiolo and J J Mieyal
    Molecular Pharmacology January 1982, 21 (1) 1-4;
  • You have access
    Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.
    A De Lean, A A Hancock and R J Lefkowitz
    Molecular Pharmacology January 1982, 21 (1) 5-16;
  • You have access
    Alpha 2-adrenergic receptors in neuroblastoma x glioma hybrid cells. Characterization with agonist and antagonist radioligands and relationship to adenylate cyclase.
    D J Kahn, J C Mitrius and D C U'Prichard
    Molecular Pharmacology January 1982, 21 (1) 17-26;
  • You have access
    Regulation of autonomic receptors in rat submandibular gland.
    D B Bylund, J R Martinez and D L Pierce
    Molecular Pharmacology January 1982, 21 (1) 27-35;
  • You have access
    Apparent "down-regulation" of human platelet alpha 2-adrenergic receptors is due to retained agonist.
    J S Karliner, H J Motulsky and P A Insel
    Molecular Pharmacology January 1982, 21 (1) 36-43;
  • You have access
    Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    M W Hamblin and I Creese
    Molecular Pharmacology January 1982, 21 (1) 44-51;
  • You have access
    Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
    M W Hamblin and I Creese
    Molecular Pharmacology January 1982, 21 (1) 52-56;
  • You have access
    Kinetics of [3H]flunitrazepam binding to membrane-bound benzodiazepine receptors.
    T H Chiu, D M Dryden and H C Rosenberg
    Molecular Pharmacology January 1982, 21 (1) 57-65;
  • You have access
    Muscarinic cholinergic receptors on cultured thyroid cells. I. Biological effect of carbachol and characterization of the receptors.
    S Champion and J Mauchamp
    Molecular Pharmacology January 1982, 21 (1) 66-72;
  • You have access
    Muscarinic cholinergic receptors on cultured thyroid cells. II. Carbachol-induced desensitization.
    S Champion and J Mauchamp
    Molecular Pharmacology January 1982, 21 (1) 73-77;
  • You have access
    Human polymorphonuclear neutrophils. Pharmacological characterization of histamine receptors mediating the elevation of cyclic AMP.
    C Gespach and J P Abita
    Molecular Pharmacology January 1982, 21 (1) 78-85;
  • You have access
    Interaction of beta-endorphin and other opioid peptides with calmodulin.
    M Sellinger-Barnette and B Weiss
    Molecular Pharmacology January 1982, 21 (1) 86-91;
  • You have access
    Study of the interaction between human serum albumin and some cephalosporins.
    C Briand, M Sarrazin, V Peyrot, R Gilli, M Bourdeaux and J C Sari
    Molecular Pharmacology January 1982, 21 (1) 92-99;
  • You have access
    Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
    V Maes, Y Engelborghs, J Hoebeke, Y Maras and A Vercruysse
    Molecular Pharmacology January 1982, 21 (1) 100-107;
  • You have access
    Characterization of S-adenosylhomocysteine binding to isolated rat hepatocytes and purified rat liver plasma membranes. Effect of analogues of S-adenosylhomocysteine.
    P M Ueland, J Aarbakke and A Bessesen
    Molecular Pharmacology January 1982, 21 (1) 108-113;
  • You have access
    The autoreceptor control of dopamine synthesis. An in vitro and in vivo comparison of dopamine agonists.
    D R Haubrich and A B Pflueger
    Molecular Pharmacology January 1982, 21 (1) 114-120;
  • You have access
    Rat parotid gland protein kinase activation. Relationship to enzyme secretion.
    T N Spearman and F R Butcher
    Molecular Pharmacology January 1982, 21 (1) 121-127;
  • You have access
    Alpha1-adrenergic stimulation of phosphatidylinositol-phosphatidic acid turnover in rat parotid cells.
    T Uchida, H Ito, B J Baum, G S Roth, C R Filburn and B Sacktor
    Molecular Pharmacology January 1982, 21 (1) 128-132;
  • You have access
    Metabolism of N-alkyl compounds during the biosynthesis of prostaglandins. N-Dealkylation during prostaglandin biosynthesis.
    K Sivarajah, J M Lasker, T E Eling and M B Abou-Donia
    Molecular Pharmacology January 1982, 21 (1) 133-141;
  • You have access
    Inhibition of prostaglandin synthesis antagonizes the colchicine-induced reduction of vasopressin-stimulated water flow in the toad urinary bladder.
    R M Burch and P V Halushka
    Molecular Pharmacology January 1982, 21 (1) 142-149;
  • You have access
    The influence of organometals on heme metabolism. In vivo and in vitro studies with organotins.
    D W Rosenberg, G S Drummond and A Kappas
    Molecular Pharmacology January 1982, 21 (1) 150-158;
  • You have access
    Suicide inactivation of hamster hepatic arylhydroxamic acid N,O-acyltransferase. A selective probe of N-acetyltransferase multiplicity.
    P E Hanna, R B Banks and V C Marhevka
    Molecular Pharmacology January 1982, 21 (1) 159-165;
  • You have access
    Further studies of the suicide inactivation of purified rat liver cytochrome P-450 by chloramphenicol.
    J Halpert
    Molecular Pharmacology January 1982, 21 (1) 166-172;
  • You have access
    Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione.
    D F Covey and W F Hood
    Molecular Pharmacology January 1982, 21 (1) 173-180;
  • You have access
    Inhibition of calf thymus and rat hypothalamic synaptosomal protein carboxymethyltransferase by analogues of S-adenosylhomocysteine.
    R T Borchardt, D Kuonen, J A Huber and A Moorman
    Molecular Pharmacology January 1982, 21 (1) 181-186;
  • You have access
    Ames test and antitumor activity of 1-(X-phenyl)-3,3-dialkyltriazenes. Quantitative structure-activity studies based upon molecular shape analysis.
    A J Hopfinger and R Potenzone
    Molecular Pharmacology January 1982, 21 (1) 187-195;
  • You have access
    The antitumor effects of anthracyclines. II. The stereospecificity of the carbomethoxy group at position 10 of the class II anthracycline molecule.
    V H DuVernay, D Eubanks, R Perales, A W Prestayko and S T Crooke
    Molecular Pharmacology January 1982, 21 (1) 196-203;
  • You have access
    Biochemical and cell cycle perturbations in methotrexate-treated cells.
    I W Taylor, P Slowiaczek, P R Francis and M H Tattersall
    Molecular Pharmacology January 1982, 21 (1) 204-210;
  • You have access
    Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
    H A Ingraham, B Y Tseng and M Goulian
    Molecular Pharmacology January 1982, 21 (1) 211-216;
  • You have access
    Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
    E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker
    Molecular Pharmacology January 1982, 21 (1) 217-223;
  • You have access
    Biochemical interactions between N-(phosphonacetyl)-L-aspartate and 5-fluorouracil.
    C M Liang, R C Donehower and B A Chabner
    Molecular Pharmacology January 1982, 21 (1) 224-230;
  • You have access
    Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells.
    B A Domin, Y C Cheng and M T Hakala
    Molecular Pharmacology January 1982, 21 (1) 231-238;
  • You have access
    Epidermis: a site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity.
    D R Bickers, T Dutta-Choudhury and H Mukhtar
    Molecular Pharmacology January 1982, 21 (1) 239-247;
  • You have access
    Monoclonal antibodies to rabbit liver cytochrome P-450LM2 and cytochrome P-450LM4.
    S S Park, S J Cha, H Miller, A V Persson, M J Coon and H V Gelboin
    Molecular Pharmacology January 1982, 21 (1) 248-258;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 21, Issue 1
1 Jan 1982
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics